Invention Grant
US08906863B2 Proteolysis-resistant capsid of chimeric hepatitis E virus as an oral delivery vector
有权
作为口服递送载体的嵌合型戊型肝炎病毒的蛋白水解抗性衣壳
- Patent Title: Proteolysis-resistant capsid of chimeric hepatitis E virus as an oral delivery vector
- Patent Title (中): 作为口服递送载体的嵌合型戊型肝炎病毒的蛋白水解抗性衣壳
-
Application No.: US13224151Application Date: 2011-09-01
-
Publication No.: US08906863B2Publication Date: 2014-12-09
- Inventor: R. Holland Cheng , Li Xing
- Applicant: R. Holland Cheng , Li Xing
- Applicant Address: US CA Oakland
- Assignee: The Regents of the University of California
- Current Assignee: The Regents of the University of California
- Current Assignee Address: US CA Oakland
- Agency: Kilpatrick Townsend & Stockton LLP
- Main IPC: A61K38/16
- IPC: A61K38/16 ; A61K39/21 ; C07K16/10 ; C07K14/005 ; A61K39/29 ; A61K39/00
Abstract:
This invention provides a peptide/nucleic acid composition for oral/mucosal, dual-modal activation of immune protection systems.
Public/Granted literature
- US20120301494A1 PROTEOLYSIS-RESISTANT CAPSID OF CHIMERIC HEPATITIS E VIRUS AS AN ORAL DELIVERY VECTOR Public/Granted day:2012-11-29
Information query
IPC分类:
